Yves Gruel

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Adam Cuker, Gowthami M. Arepally, Beng H. Chong et al. · Blood Advances · 2018 · 719 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin

Claire Pouplard, Marc‐Antoine May, Sophie Iochmann et al. · Circulation · 1999 · 303 citations

Medicine, Hematology, Immunology +13

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin

Pierre Savi, Beng H. Chong, Andreas Greinacher et al. · Blood · 2004 · 210 citations · Full text

Medicine, Pharmacotherapy, Hemostasis +10

Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis

Guillaume Cayla, Jean‐Sébastien Hulot, Stephen O’Connor et al. · JAMA · 2011 · 201 citations

Life Sciences, Cardiology, Genetics +17

Induction of monocyte tissue factor expression by antibodies to heparin–platelet factor 4 complexes developed in heparin-induced thrombocytopenia

Claire Pouplard, Sophie Iochmann, B. Renard et al. · Blood · 2001 · 196 citations · Full text

Medicine, Hematology, Immunology +14